DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype
Giulia Maurizi; Domenico Mattiucci; Marianna Mariani; Marco Ciarlantini; Sabrina Traini; Stefania Mancini; Attilio Olivieri; Pietro Leoni; Antonella Poloni
Author Information: Clinica di Ematologia
Checking for direct PDF access through Ovid |
Abstract
Abstract unavailable for this article.